Provided by Tiger Fintech (Singapore) Pte. Ltd.

Janux Therapeutics, Inc.

25.46
-0.7800-2.97%
Volume:605.45K
Turnover:15.75M
Market Cap:1.51B
PE:-18.65
High:26.98
Open:26.39
Low:25.44
Close:26.24
Loading ...
Sep 10, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 10, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 10, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 10, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 10, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 06, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 06, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 06, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 09, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Aug 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 07, 2024

Major Issues Report

Form 8-K - Current report
Jul 22, 2024

Major Issues Report

Form 8-K - Current report
Jun 28, 2024

Major Issues Report

Form 8-K - Current report
Jun 05, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jun 04, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 04, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 04, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities